1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Basal Ganglia Hemorrhage: new trials by email Literature Review of Basal Ganglia Hemorrhage trials Research Report on Basal Ganglia Hemorrhage
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation Apixaban Oral Tablet, Dabigatran, Edoxaban Tablets - Atrial Fibrillation, Intracerebral Hemorrhage | Phase 3 | Completed | Imperial College London | 319 | 2019-06-03 | 2025-01-13 |
Arrhythmias, Cardiac (1) · Atrial Fibrillation (1) · Cerebral Hemorrhage (1) · Intracranial Hemorrhages (1)
Basal Ganglia Cerebrovascular Disease (1) · Basal Ganglia Diseases (1) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Heart Diseases (1) · Hemorrhage (1) · Nervous System Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Vascular Diseases (1)
Dabigatran (1) · Rivaroxaban (1) · apixaban (1) · edoxaban (1)
Austria (1) · France (1) · Germany (1) · Italy (1) · Spain (1) · United Kingdom (1)
PMID 34022170, PMID 36700520, PMID 40023176, PMID 41197104
2018 (1)